ZANAFLEX

This brand name is authorized in United States. It is also authorized in Ireland.

Active ingredients

The drug ZANAFLEX contains one active pharmaceutical ingredient (API):

1	Tizanidine UNII B53E3NMY5C - TIZANIDINE HYDROCHLORIDE
	Tizanidine is a centrally acting skeletal muscle relaxant. Polysynaptic signal transmission at spinal interneuron level, which is responsible for excessive muscle tone, is inhibited and muscle tone reduced.
	Read more about Tizanidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZANAFLEX Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03BX02	Tizanidine	M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BX Other centrally acting agents
Discover more medicines within M03BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
IE	Health Products Regulatory Authority	54410, 54424, 54431, 54449
US	FDA, National Drug Code	70515-594, 70515-602, 70515-604, 70515-606, 80425-0022, 80425-0023, 80425-0024